256 related articles for article (PubMed ID: 9542910)
1. Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Davey KG; Holmes AD; Johnson EM; Szekely A; Warnock DW
J Clin Microbiol; 1998 Apr; 36(4):926-30. PubMed ID: 9542910
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
Davey KG; Szekely A; Johnson EM; Warnock DW
J Antimicrob Chemother; 1998 Oct; 42(4):439-44. PubMed ID: 9818741
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Swinne D; Raes-Wuytack C; Van Looveren K; Desmet P
Mycoses; 1999; 42(4):231-7. PubMed ID: 10424089
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
To WK; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
[TBL] [Abstract][Full Text] [Related]
6. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
Barchiesi F; Colombo AL; McGough DA; Rinaldi MG
J Clin Microbiol; 1994 Oct; 32(10):2494-500. PubMed ID: 7814488
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Willinger B; Apfalter P; Hirschl AM; Makristathis A; Rotter M; Seibold M
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):11-5. PubMed ID: 11025178
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
Colombo AL; Barchiesi F; McGough DA; Rinaldi MG
J Clin Microbiol; 1995 Mar; 33(3):535-40. PubMed ID: 7751353
[TBL] [Abstract][Full Text] [Related]
11. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
13. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.
Espinel-Ingroff A; Kerkering TM; Goldson PR; Shadomy S
J Clin Microbiol; 1991 Jun; 29(6):1089-94. PubMed ID: 1864923
[TBL] [Abstract][Full Text] [Related]
14. Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans.
Barchiesi F; Del Poeta M; Morbiducci V; Ancarani F; Scalise G
Mycopathologia; 1993 Oct; 124(1):19-25. PubMed ID: 8159215
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
[TBL] [Abstract][Full Text] [Related]
16. Flucytosine primary resistance in Candida species and Cryptococcus neoformans.
Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Rodríguez-Tudela JL
Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):276-9. PubMed ID: 11399020
[TBL] [Abstract][Full Text] [Related]
17. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
Chen SC; O'Donnell ML; Gordon S; Gilbert GL
J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736
[TBL] [Abstract][Full Text] [Related]
19. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
